vTv Therapeutics
VTVT
VTVT
44 hedge funds and large institutions have $22.1M invested in vTv Therapeutics in 2017 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
44
Holders Change
+7
Holders Change %
+18.92%
% of All Funds
1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
13
Reduced
12
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
RA
Royce & Associates
New York
|
$1.35M |
| 2 |
JPMorgan Chase & Co
New York
|
$1.26M |
| 3 |
Millennium Management
New York
|
$377K |
| 4 |
Creative Planning
Overland Park,
Kansas
|
$114K |
| 5 |
State Street
Boston,
Massachusetts
|
$673K |
Top Sellers
| 1 |
BlackRock
New York
|
$2.07M |
| 2 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
$541K |
| 3 |
Franklin Resources
San Mateo,
California
|
$5.11M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
$1.14M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
$1.69M |
